X

Trial Profile

A Global, open label, parallel-arm and randomized controlled clinical trial designed to evaluate the efficacy and safety of investigational AVR-RD-02

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II/III

Latest Information Update: 14 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AVR RD 02 (Primary)
Indications Gaucher's disease type III
Focus Registrational; Therapeutic Use
Acronyms Guard3

Most Recent Events

07 Aug 2023 Status changed from not yet recruiting to withdrawn prior to enrolment.
11 May 2023 According to AVROBIO media release, the company expect to initiate this trial later this year.
20 Apr 2023 Status changed from planning to not yet recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com